AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14709757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11239180 — intervention group
Group type: COMPARATOR
Intervention: Magnetization Transfer Imaging (MTI)
Number of subjects: 33
Study 9632036 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 120
Study 9632036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 9753961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.1 mg 3 min prior to propofol
Number of subjects: 160
Study 9753961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 40 mg added to 200 mg propofol
Number of subjects: 160
Study 9753961 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2 mg.kg‐1
Number of subjects: 160
Study 9753961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.1 mg 3 min prior to propofol mixed with lidocaine 40 mg
Number of subjects: 160
Study 9753961 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection via the forearm vein
Number of subjects: 160
Study 9753961 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups receiving fentanyl
Number of subjects: 160
Study 2497096 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaprozin 600 mg/day
Number of subjects: 34
Study 2497096 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg t.i.d.
Number of subjects: 34
Study 2497096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% carbonated lignocaine
Number of subjects: 335
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine HCl
Number of subjects: 335
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% carbonated lignocaine with adrenaline
Number of subjects: 335
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine HCl with adrenaline
Number of subjects: 335
Study 130153 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 335
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain lignocaine
Number of subjects: 335
Study 130153 — intervention group
Group type: EXPERIMENTAL
Intervention: Other groups
Number of subjects: 335
Study 30585904 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 27
Study 30585904 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 27
Study 30585904 — intervention group
Group type: COMPARATOR
Intervention: Daily caffeine intake
Number of subjects: 27
Study 29388827 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-oriented education and support (CES)
Number of subjects: 30
Study 29388827 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and support (PES)
Number of subjects: 30
Study 29388827 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 30
Study 28861902 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-led Body Project groups
Number of subjects: 680
Study 28861902 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led Body Project groups
Number of subjects: 680
Study 28861902 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based version of the Body Project (eBodyProject)
Number of subjects: 680
Study 28861902 — intervention group
Group type: COMPARATOR
Intervention: Educational video control condition
Number of subjects: 680
Study 26742334 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy by group 1 SRNAs
Number of subjects: 9
Study 26742334 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy after observing video laryngoscopy by group 2 SRNAs
Number of subjects: 9
Study 23937756 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive unilateral pedicle screw fixation
Number of subjects: 85
Study 23937756 — intervention group
Group type: COMPARATOR
Intervention: Classic bilateral pedicle screw fixation
Number of subjects: 85
Study 21285389 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegAsp
Number of subjects: 178
Study 21285389 — intervention group
Group type: EXPERIMENTAL
Intervention: AF
Number of subjects: 178
Study 21285389 — intervention group
Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 178
Study 19253130 — intervention group
Group type: EXPERIMENTAL
Intervention: AMP-RT (in-home asthma management program provided by respiratory therapists)
Number of subjects: 159
Study 19253130 — intervention group
Group type: EXPERIMENTAL
Intervention: AMP-RN (in-home asthma management program provided by nurses)
Number of subjects: 159
Study 19253130 — intervention group
Group type: COMPARATOR
Intervention: UC (usual care provided in physician offices or clinics)
Number of subjects: 159
Study 16884070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmenoxime hydrochloride (CMX)
Number of subjects: 0
Study 16884070 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (AT)
Number of subjects: 0
Study 15256687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of whey protein (17.5 g), amino acids (4.9 g), and carbohydrates (77.4 g) (PAAC)
Number of subjects: 8
Study 15256687 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrates (100 g) (CON)
Number of subjects: 8
Study 11282765 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic nasal continuous positive airway pressure (CPAP)
Number of subjects: 46
Study 11282765 — intervention group
Group type: COMPARATOR
Intervention: Subtherapeutic nasal continuous positive airway pressure (CPAP) (0-1 cm H(2)O)
Number of subjects: 46
Study 11282765 — intervention group
Group type: COMPARATOR
Intervention: Ineffective nasal continuous positive airway pressure (CPAP)
Number of subjects: 46
Study 9137476 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐galactose (1.9 g/kg BW and day)
Number of subjects: 76
Study 9137476 — intervention group
Group type: COMPARATOR
Intervention: D‐glucose‐containing electrolyte infusions
Number of subjects: 76
Study 7964541 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-galactosidase solution (8 drops)
Number of subjects: 19
Study 7964541 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 drops)
Number of subjects: 19
Study 3058656 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic bed irradiation only (6500 cGy at 180‐200 cGy per treatment)
Number of subjects: 445
Study 3058656 — intervention group
Group type: COMPARATOR
Intervention: Pelvic node irradiation to 4500 cGy with a boost of 2000 cGy to the prostatic bed (total dose 6500 cGy)
Number of subjects: 445
Study 31022069 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2
Number of subjects: 30
Study 31022069 — intervention group
Group type: COMPARATOR
Intervention: ICBG
Number of subjects: 30
Study 28254694 — intervention group
Group type: EXPERIMENTAL
Intervention: Training (T)
Number of subjects: 60
Study 28254694 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-reduced diet (D)
Number of subjects: 60
Study 28254694 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and increased diet (T-iD)
Number of subjects: 60
Study 28254694 — intervention group
Group type: COMPARATOR
Intervention: Sedentary lifestyle and unchanged diet (C)
Number of subjects: 60
Study 25611899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpegylated doxorubicin citrate (60 mg/m) and carboplatin (AUC 5) every 3 weeks for 6 to 9 cycles
Number of subjects: 39
Study 25611899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpegylated doxorubicin citrate and carboplatin
Number of subjects: 39
Study 23994252 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based CBT
Number of subjects: 81
Study 21516059 — intervention group
Group type: COMPARATOR
Intervention: Levothyroxine sodium soft capsule formulation (Tirosint)
Number of subjects: 90
Study 21516059 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-, 100-, and 150-μg test capsules strengths dosed at 600 μg
Number of subjects: 90
Study 21516059 — intervention group
Group type: COMPARATOR
Intervention: New capsule formulation following the new potency guideline (±5%)
Number of subjects: 90
Study 18377142 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone psychotherapy for depression
Number of subjects: 127
Study 16601647 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (10-50 mg/day)
Number of subjects: 449
Study 16601647 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 449
Study 16601647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study 12594688 — intervention group
Group type: EXPERIMENTAL
Intervention: Angio‐Seal
Number of subjects: 612
Study 12594688 — intervention group
Group type: COMPARATOR
Intervention: Compression methods
Number of subjects: 612
Study 10733124 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432 and fibrinogen plus 5'‐deoxy‐5‐fluorouridine
Number of subjects: 20
Study 10733124 — intervention group
Group type: COMPARATOR
Intervention: 5'‐deoxy‐5‐fluorouridine only
Number of subjects: 20
Study 8738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative platelet count (PlC) levels
Number of subjects: 438
Study 8738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative platelet count (PlC) quartiles
Number of subjects: 438
Study 8738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative platelet count (PlC) levels adjusted for age, sex, type of surgery and type of prophylaxis
Number of subjects: 438
Study 1305891 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐n3 (Alferon N Injection)
Number of subjects: 3
Study 1305891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 2867653 — intervention group
Group type: COMPARATOR
Intervention: etintidine 300 mg
Number of subjects: 0
Study 2867653 — intervention group
Group type: COMPARATOR
Intervention: etintidine 600 mg
Number of subjects: 0
Study 2867653 — intervention group
Group type: COMPARATOR
Intervention: cimetidine 800 mg
Number of subjects: 0
Study 2867653 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 300 mg
Number of subjects: 0
Study 29779912 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural analgesia or sedation during painful procedures
Number of subjects: 229
Study 29779912 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal suctioning
Number of subjects: 229
Study 29779912 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-breaking procedures
Number of subjects: 229
Study 29779912 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically ventilated patients
Number of subjects: 229
Study 29779912 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall number of painful and stressful procedures
Number of subjects: 229
Study 30020219 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise program
Number of subjects: 43
Study 30020219 — intervention group
Group type: COMPARATOR
Intervention: No exercise control
Number of subjects: 43
Study 27209237 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic intraoperative neuromonitoring (pIONM)
Number of subjects: 188
Study 27209237 — intervention group
Group type: COMPARATOR
Intervention: No pelvic intraoperative neuromonitoring (pIONM)
Number of subjects: 188
Study 25209306 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone initiation in primary care
Number of subjects: 195
Study 25209306 — intervention group
Group type: COMPARATOR
Intervention: Methadone initiation in specialized centers
Number of subjects: 195
Study 25209306 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in a couple with a non-drug user
Number of subjects: 195
Study 25209306 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in a couple with a drug user
Number of subjects: 195
Study 21989542 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg weekly
Number of subjects: 752
Study 21989542 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg twice weekly
Number of subjects: 752
Study 21989542 — intervention group
Group type: COMPARATOR
Intervention: Etanercept (both doses)
Number of subjects: 752
Study 20979784 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPTH (1‐34) 20 µg daily
Number of subjects: 205
Study 20979784 — intervention group
Group type: COMPARATOR
Intervention: elcatonin 20 U weekly
Number of subjects: 205
Study 20979784 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPTH (1‐34)
Number of subjects: 205
Study 18729145 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week exercise intervention
Number of subjects: 60
Study 18729145 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week exercise plus cognitive restructuring intervention
Number of subjects: 60
Study 18729145 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 60
Study 16093464 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate after parathyroid hormone (1-84) therapy
Number of subjects: 119
Study 16093464 — intervention group
Group type: COMPARATOR
Intervention: Placebo after parathyroid hormone (1-84) therapy
Number of subjects: 119
Study 12501881 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg administered on the last day of the OC regimen
Number of subjects: 26
Study 12501881 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethindrone 1 mg/ethinyl estradiol 0.035 mg (NE/EE)
Number of subjects: 26
Study 10626585 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal screening using transient evoked oto-acoustic emissions (TEOAE) test followed by automated auditory brainstem response (AABR) test for infants who failed TEOAE.
Number of subjects: 53781
Study 10626585 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal screening periods
Number of subjects: 53781
Study 10626585 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal screening
Number of subjects: 53781
Study 10626585 — intervention group
Group type: COMPARATOR
Intervention: Health Visitor Distraction Test (HVDT) screening
Number of subjects: 53781
Study 7536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral temperature between 42 and 43 degrees C
Number of subjects: 91
Study 7536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral temperature between 43.1 and 45 degrees C
Number of subjects: 91
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ 89‐104, 2 mg/kg
Number of subjects: 13
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ 89‐109, 2 mg/kg
Number of subjects: 13
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ 89‐104, 0.5 mg/kg
Number of subjects: 13
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ 89‐109, 0.5 mg/kg
Number of subjects: 13
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum levels (2 mg/kg)
Number of subjects: 13
Study 1645384 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum half-lives
Number of subjects: 13
Study 7098411 — intervention group
Group type: EXPERIMENTAL
Intervention: Kavinton
Number of subjects: 8
Study 7098411 — intervention group
Group type: COMPARATOR
Intervention: Scopolamine
Number of subjects: 8
Study 7098411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31864339 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention program including self-management education and measurement of weight, waist circumference, and blood pressure for 3 months.
Number of subjects: 92
Study 31864339 — intervention group
Group type: COMPARATOR
Intervention: Leaflet on the importance of controlling hypertension.
Number of subjects: 92
Study 28738008 — intervention group
Group type: EXPERIMENTAL
Intervention: Yunnan Baiyao (15 mg/kg)
Number of subjects: 12
Study 28738008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 25941765 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (300 mg per day for 20 days)
Number of subjects: 18
Study 25941765 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation (300 mg per day for 20 days)
Number of subjects: 18
Study 25941765 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CoQ10 and placebo)
Number of subjects: 18
Study 24885672 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Western medicine (Salbutamol, Formoterol, Salmeterol/fluticasone)
Number of subjects: 360
Study 24885672 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) treatments (Bufei granule, Bu‐Fei Jian‐Pi granule, Bu‐Fei Yi‐Shen granule, Yi‐Qi Zi‐Shen granule)
Number of subjects: 360
Study 24885672 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of conventional Western medicine and TCM treatments
Number of subjects: 360
Study 24885672 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 360
Study 22131604 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT plus BLT
Number of subjects: 49
Study 22131604 — intervention group
Group type: COMPARATOR
Intervention: WL
Number of subjects: 49
Study 20165628 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise (brisk walking for 50-60 minutes, four days/week)
Number of subjects: 113
Study 20165628 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt intake reduction (to at least half of previous intake)
Number of subjects: 113
Study 20165628 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (30-45 minutes/day on at least five days/week)
Number of subjects: 113
Study 20165628 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113
Study 17445432 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 300 mg loading dose
Number of subjects: 60
Study 17445432 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose
Number of subjects: 60
Study 17445432 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (300 mg and 600 mg)
Number of subjects: 60
Study 14709457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 10 mg.kg(‐1) bolus before surgery plus a 1 mg.kg(‐1).hr(‐1) infusion until wound closure (Group TA)
Number of subjects: 40
Study 14709457 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 40
Study 11470689 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dk RGP lenses
Number of subjects: 201
Study 11470689 — intervention group
Group type: COMPARATOR
Intervention: Medium Dk RGP lenses
Number of subjects: 201
Study 9737091 — intervention group
Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg/d for 6 days
Number of subjects: 15
Study 9737091 — intervention group
Group type: EXPERIMENTAL
Intervention: indomethacin 25 mg tid for 2 days and 25 mg on the 3rd day
Number of subjects: 15
Study 9737091 — intervention group
Group type: COMPARATOR
Intervention: no NSAID (control)
Number of subjects: 15
Study 7995320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfiltered 0 mg nicotine cigarette
Number of subjects: 20
Study 7995320 — intervention group
Group type: EXPERIMENTAL
Intervention: Low (0.27 mg) nicotine cigarette
Number of subjects: 20
Study 7995320 — intervention group
Group type: EXPERIMENTAL
Intervention: High (2.16 mg) nicotine cigarette
Number of subjects: 20
Study 7995320 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 20
Study 2843029 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat and bean products as dietary supplements
Number of subjects: 0
Study 2843029 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate, high-fiber diets
Number of subjects: 0
Study 29966645 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive group treatment (13 weekly sessions, 1.5 hours each) with structured and facilitated group interactions
Number of subjects: 179
Study 29966645 — intervention group
Group type: COMPARATOR
Intervention: Noninteractive treatment (13 traditional classroom sessions with brief supplemental individual sessions)
Number of subjects: 179
Study 26867200 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation alone
Number of subjects: 86
Study 26867200 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA as part of a multinutrient supplement (including Gingko biloba, phosphatidylserine, vitamins B₉ and B₁₂)
Number of subjects: 86
Study 25654524 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of health protection and health promotion with a continuous improvement system (Kaizen)
Number of subjects: 500
Study 25654524 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 500
Study 23409693 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 40
Study 23409693 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 40
Study 20530001 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI) with paclitaxel-eluting stents
Number of subjects: 705
Study 20530001 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 705
Study 20530001 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 705
Study 20530001 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 705
Study 18702660 — intervention group
Group type: EXPERIMENTAL
Intervention: EC‐MPS (1080 mg bid)
Number of subjects: 154
Study 18702660 — intervention group
Group type: COMPARATOR
Intervention: MMF (1500 mg bid)
Number of subjects: 154
Study 18702660 — intervention group
Group type: EXPERIMENTAL
Intervention: EC‐MPS
Number of subjects: 154
Study 18702660 — intervention group
Group type: COMPARATOR
Intervention: MMF
Number of subjects: 154
Study 16880774 — intervention group
Group type: EXPERIMENTAL
Intervention: GHB (2‐18 g/70 kg)
Number of subjects: 14
Study 16880774 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 and 1 mg/70 kg)
Number of subjects: 14
Study 16880774 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbital (200 and 400 mg/70 kg)
Number of subjects: 14
Study 16880774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12761014 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor epidural analgesia
Number of subjects: 0
Study 10999559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 195
Study 10999559 — intervention group
Group type: COMPARATOR
Intervention: Low stimulation (active-control group)
Number of subjects: 195
Study 10999559 — intervention group
Group type: EXPERIMENTAL
Intervention: High stimulation
Number of subjects: 195
Study 9314121 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of psychosis
Number of subjects: 1180